Cellular, Tissue and Gene Therapies Advisory Committee
November 19, 2010, from 8:30 a.m. to 5 p.m.
Agenda: On November 19, 2010, the Committee will discuss current FDA recommendations for Testing of Replication Competent Retrovirus (RCR)/Lentivirus (RCL) in Retroviral and Lentiviral Vector Based Gene Therapy Products.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment